Elevance Health Inc.

NEW YORK, March 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether Elevance and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On March 2, 2026, Elevance disclosed in a filing with the U.S. Securities and Exchange Commission that it "was notified by the Centers for Medicare & Medicaid Services ('CMS') of its intent to impose intermediate sanctions suspending enrollment of Medicare beneficiaries into the Company's Medicare Advantage-Prescription Drug ('MA-PD') plans and suspending certain communication activities to Medicare beneficiaries."  Elevance said that "CMS has indicated that the proposed sanctions relate to alleged noncompliance by the Company with certain Medicare Advantage risk adjustment data submission requirements for dates of service prior to April 3, 2023" and that "[t]he sanctions are scheduled to take effect on March 31, 2026 unless CMS determines that the issues identified have been satisfactorily addressed." 

On this news, Elevance's stock price fell $25.93 per share, or 8.1%, to close at $294.07 per share on March 2, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT:

Danielle Peyton

Pomerantz LLP

dpeyton@pomlaw.com

646-581-9980 ext. 7980

View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-elevance-health-inc---elv-302706087.html

SOURCE Pomerantz LLP

SAN DIEGO, Oct. 14, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that an update in the lawsuit that is currently pending for certain investors in Elevance Health, Inc. (NYSE: ELV) shares.

Investors who purchased shares of Elevance Health, Inc. (NYSE: ELV) prior to April 2024 and continue to hold any of those NYSE: ELV shares have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On March 12, 2025 an investor in NYSE: ELV shares over alleged securities laws violations by Elevance Health, Inc. The plaintiff alleged that the defendants represented to investors that they were closely monitoring cost trends associated with the redetermination process and that the premium rates Elevance was negotiating with states were sufficient to address the risk and cost profiles of those patients staying on Medicaid programs, that in fact, sicker patients with higher acuity tended to remain on Medicaid after redetermination, leading to higher per-patient costs, that this increase in cost was occurring at a rate that was not adequately reflected in Elevance's rate negotiations with the states or in its financial guidance for 2024, and that as a result, the Complaint alleges Defendants' positive statements concerning Elevance's close monitoring of the redeterminations, the actuarial soundness of its rates and the prudence of its forecasts were materially misleading and/or lacked a reasonable basis.

On October 07, 2025, an amended complaint was filed.

Those who purchased shares of Elevance Health, Inc. (NYSE: ELV) should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc. 

Michael Daniels 

+1 (858) 779-1554 

mail@shareholdersfoundation.com 

3111 Camino Del Rio North 

Suite 423 

San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-elv-lawsuit-update-investors-in-elevance-health-inc-nyse-elv-shares-should-contact-the-shareholders-foundation-in-connection-with-pending-lawsuit-302583228.html

SOURCE Shareholders Foundation, Inc.